Paul Kerr

Losses at Fusion Antibodies quadruple in ‘challenging’ period

Belfast pharmaceutical company did not recommend the payment of a dividend

Fusion Antibodies reports £700,000 loss for first trading year

Belfast company says results show ‘strong organic growth’

Fusion Antibodies raises £5.5m in London Stock Exchange debut

Belfast company to use funds to expand laboratory space and develop new service lines

RBAI dig deep to deny Methody

Inst secure a hat-trick of titles in hard-fought Ulster Schools final

Innovation finalists: making a difference in medical industry

Caterpillar blood clots, fooling the immune system and online doctors

Most Read

1

Seán Moncrieff: The nurse told me she’d never seen so much stuff come out of a human head

2

‘My girlfriend is really attractive; I’m 5ft 5in and well-rounded. I worry she will realise she can do better than me’

3

‘Bye Bye Roe’: Thousands attend Dublin anti-abortion rally celebrating US supreme court decision

4

Chinese embassy in Ireland taunts Boris Johnson over Brexit and NI Protocol

5

Mayo bookshop targeted by objectors to drag queen event

You may also like...

Listen

Audio versions of the best journalism from The Irish Times

The Irish Times ePaper